Outlook Therapeutics Incs. (OTLK) PT Lowered to $7 at H.C. Wainwright Following Stock Purchase Agreement with Syntone Ventures
Tweet Send to a Friend
H.C. Wainwright analyst Douglas Tsao lowered the price target on Outlook Therapeutics Incs. (NASDAQ: OTLK) to $7.00 (from $8.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
